Percutaneous Inserted Venous Catheter via Femoral Vein in Extremely Low-Birth-Weight Infants: A Single-Center Experience

Abstract

Objective This study aimed to assess the applicability of the insertion of small diameter catheters through the femoral vein in extremely low-birth-weight (ELBW) infants.

Study Design All femoral small diameter catheters (Silastic or femoral arterial catheter [FAC]) inserted in ELBW infants in a tertiary level neonatal intensive care unit were retrospectively reviewed. Success rate, dwelling time, and percutaneously inserted central venous catheter–related complications were recorded.

Results Thirteen small diameter catheters were inserted in seven ELBW infants. Mean gestational age at birth was 25⁺³ weeks (standard deviation [SD] ± 2.12) and mean birth weight was 686 g (SD ± 204.9). Mean weight at the first time of insertion was 1,044 g (SD ± 376.3). In two occasions, a FAC was used instead of a Silastic. In most cases (11/13, 84.6%), the patient was intubated prior to the procedure. The mean dwelling time was 16.7 days (SD ± 9.8). Most of the inserted small diameter catheters were removed electively (8/12, 66.7%), except for one episode of clinical sepsis from coagulase-negative Staphylococcus and three cases of accidental line extravasation. No other complications were reported. The success rate was 92.3%.

Conclusion Femoral venous catheterization using small diameter catheters in ELBW infants may be promising when other routes have been exhausted. Our results support that it is a feasible technique that can be performed at the bedside with successful results when conducted by experienced personnel.

Keywords

central venous catheters - intravenous catheterization - extremely premature infant - neonatal intensive care - catheter-related

Note

Written informed consent was obtained prior to the procedure from parents/legal guardian of all the patients. All patients' data were treated confidentially according to the national Data Protection Law (May 25, 2018). Institutional Review Board resolved that no review was needed given that the study was performed within routine clinical practice.

Publikationsverlauf

Eingereicht: 06. April 2019

Angenommen: 24. Juni 2019

Artikel online veröffentlicht:
09. August 2019

• References

• 1 Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ 2012; 345: e7976
• 2 Tsai MH, Chu SM, Lien R. et al. Complications associated with 2 different types of percutaneously inserted central venous catheters in very low birth weight infants. Infect Control Hosp Epidemiol 2011; 32 (03) 258-266
• 3 Tsai MH, Lien R, Wang JW. et al. Complication rates with central venous catheters inserted at femoral and non-femoral sites in very low birth weight infants. Pediatr Infect Dis J 2009; 28 (11) 966-970
• 4 Wardle SP, Kelsall AW, Yoxall CW, Subhedar NV. Percutaneous femoral arterial and venous catheterisation during neonatal intensive care. Arch Dis Child Fetal Neonatal Ed 2001; 85 (02) F119-F122
• 5 Serrao PR, Jean-Louis J, Godoy J, Prado A. Inferior vena cava catheterization in the neonate by the percutaneous femoral vein method. J Perinatol 1996; 16 (2 Pt 1): 129-132
• 6 Trieschmann U, Kruessell M, Cate UT, Sreeram N. Central venous catheters in children and neonates (part 3) - access via the femoral vein. Images Paediatr Cardiol 2008; 10 (03) 1-9
• 7 Karapinar B, Cura A. Complications of central venous catheterization in critically ill children. Pediatr Int 2007; 49 (05) 593-599
• 8 Chen KB. Clinical experience of percutaneous femoral venous catheterization in critically ill preterm infants less than 1,000 grams. Anesthesiology 2001; 95 (03) 637-639
• 9 Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila) 1997; 36 (06) 311-319
• 10 Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA. Central venous catheter insertion by femoral vein: safety and effectiveness for the pediatric patient. Pediatrics 1986; 77 (06) 842-847
• 11 Dolcourt JL, Bose CL. Percutaneous insertion of Silastic central venous catheters in newborn infants. Pediatrics 1982; 70 (03) 484-486
• 12 Erhard DM, Nguyen S, Guy KJ, Casalaz DM, König K. Dwell times and risk of non-elective removal of 1-French peripherally inserted central catheters according to catheter tip position in very preterm infants. Eur J Pediatr 2017; 176 (03) 407-411
• 13 Freeman JJ, Gadepalli SK, Siddiqui SM, Jarboe MD, Hirschl RB. Improving central line infection rates in the neonatal intensive care unit: Effect of hospital location, site of insertion, and implementation of catheter-associated bloodstream infection protocols. J Pediatr Surg 2015; 50 (05) 860-863
• 14 O'Grady NP, Alexander M, Burns LA. et al; Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011; 39 (04) (Suppl. 01) S1-S34
• 15 Lim SH, Smith MP, Salooja N, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. J Antimicrob Chemother 1991; 28 (01) 109-116
• 16 Carratalà J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 2001; 7 (Suppl. 04) 83-90
• 17 Saugel B, Scheeren TWL, Teboul JL. Ultrasound-guided central venous catheter placement: a structured review and recommendations for clinical practice. Crit Care 2017; 21 (01) 225